HTGM
Income statement / Annual
Last year (2022), HTG Molecular Diagnostics, Inc.'s total revenue was $6.37 M,
a decrease of 28.52% from the previous year.
In 2022, HTG Molecular Diagnostics, Inc.'s net income was -$21.59 M.
See HTG Molecular Diagnostics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$6.37 M
|
$8.91 M
|
$8.55 M
|
$19.20 M
|
$21.50 M
|
$14.76 M
|
$5.13 M
|
$4.04 M
|
$3.33 M
|
$2.24 M
|
| Cost of Revenue |
$4.57 M |
$4.09 M |
$3.99 M |
$8.91 M |
$5.09 M |
$4.97 M |
$4.14 M |
$3.34 M |
$3.20 M |
$2.25 M |
| Gross Profit |
$1.79 M |
$4.81 M |
$4.56 M |
$10.29 M |
$16.41 M |
$9.79 M |
$996,846.00 |
$706,064.00 |
$124,042.00 |
-$3,826.00 |
| Gross Profit Ratio |
0.28 |
0.54 |
0.53 |
0.54 |
0.76 |
0.66 |
0.19 |
0.17 |
0.04 |
-0 |
| Research and Development
Expenses |
$6.78 M
|
$6.09 M
|
$6.08 M
|
$10.57 M
|
$12.60 M
|
$10.00 M
|
$7.90 M
|
$4.60 M
|
$3.08 M
|
$4.20 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$19.97 M
|
$17.51 M
|
$17.43 M
|
$14.99 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$15.84 M
|
$16.55 M
|
$18.06 M
|
$18.68 M
|
$19.97 M
|
$17.51 M
|
$17.43 M
|
$14.99 M
|
$0.00
|
$0.00
|
| Other Expenses |
$8,333.00 |
-$1.03 M |
$22,268.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$9.90 M |
$7.71 M |
| Operating Expenses |
$22.62 M |
$22.64 M |
$24.14 M |
$29.25 M |
$32.57 M |
$27.51 M |
$25.33 M |
$19.60 M |
$12.97 M |
$11.91 M |
| Cost And Expenses |
$27.20 M |
$26.73 M |
$28.13 M |
$38.16 M |
$37.66 M |
$32.48 M |
$29.46 M |
$22.93 M |
$16.18 M |
$14.16 M |
| Interest Income |
$94,355.00 |
$29,884.00 |
$254,736.00 |
$623,355.00 |
$715,723.00 |
$73,178.00 |
$112,413.00 |
$85,859.00 |
$0.00 |
$0.00 |
| Interest Expense |
$856,731.00 |
$1.06 M |
$1.02 M |
$957,535.00 |
$901,820.00 |
$1.31 M |
$1.87 M |
$1.72 M |
$706,866.00 |
$211,872.00 |
| Depreciation &
Amortization |
$689,826.00
|
-$1.74 M
|
$1.62 M
|
$2.36 M
|
$1.47 M
|
$1.24 M
|
$1.47 M
|
$662,562.00
|
$496,595.00
|
$315,086.00
|
| EBITDA |
-$20.14 M
|
-$19.56 M
|
-$17.96 M
|
-$16.60 M
|
-$14.08 M
|
-$16.41 M
|
-$22.69 M
|
-$19.01 M
|
-$12.75 M
|
-$11.24 M
|
| EBITDA Ratio |
-3.16 |
-2.2 |
-2.1 |
-0.86 |
-0.65 |
-1.11 |
-4.42 |
-4.7 |
-3.83 |
-5.01 |
| Operating Income Ratio
|
-3.27
|
-2
|
-2.29
|
-0.99
|
-0.75
|
-1.2
|
-4.74
|
-4.67
|
-3.86
|
-5.31
|
| Total Other
Income/Expenses Net |
-$754,043.00
|
$701,131.00
|
-$1.27 M
|
-$334,180.00
|
-$291,161.00
|
-$1.23 M
|
-$1.70 M
|
-$2.50 M
|
-$1.11 M
|
$146,047.00
|
| Income Before Tax |
-$21.58 M |
-$17.12 M |
-$20.86 M |
-$19.29 M |
-$16.45 M |
-$18.96 M |
-$26.03 M |
-$21.39 M |
-$13.96 M |
-$11.77 M |
| Income Before Tax Ratio
|
-3.39
|
-1.92
|
-2.44
|
-1
|
-0.76
|
-1.28
|
-5.07
|
-5.29
|
-4.19
|
-5.25
|
| Income Tax Expense |
$10,837.00 |
$22,475.00 |
$14,415.00 |
$3,379.00 |
$3,526.00 |
$2,921.00 |
$10,118.00 |
$10,189.00 |
-$402,683.00 |
$357,919.00 |
| Net Income |
-$21.59 M |
-$17.15 M |
-$20.87 M |
-$19.30 M |
-$16.45 M |
-$18.96 M |
-$26.04 M |
-$21.40 M |
-$13.96 M |
-$11.77 M |
| Net Income Ratio |
-3.39 |
-1.92 |
-2.44 |
-1 |
-0.77 |
-1.28 |
-5.07 |
-5.29 |
-4.19 |
-5.25 |
| EPS |
-24.28 |
-29.66 |
-54.12 |
-91.17 |
-0.75 |
-2.24 |
-4.58 |
-5.92 |
-52.33 |
-44.13 |
| EPS Diluted |
-24.28 |
-29.66 |
-54.12 |
-91.17 |
-0.75 |
-2.24 |
-4.58 |
-5.92 |
-5.95 |
-44.13 |
| Weighted Average Shares
Out |
$889,284.00
|
$578,011.00
|
$385,659.00
|
$211,664.00
|
$22.02 M
|
$8.48 M
|
$5.69 M
|
$3.61 M
|
$266,724.00
|
$266,724.00
|
| Weighted Average Shares
Out Diluted |
$889,284.00
|
$578,011.00
|
$385,659.00
|
$211,664.00
|
$22.02 M
|
$8.48 M
|
$5.69 M
|
$3.61 M
|
$2.35 M
|
$266,724.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
